This episode of Making Medicine features Christine Brennan, Managing Director, Vertex Venture HC, where we discuss how diversity, equity, and inclusion are critical for the life sciences industry.
Incubate advocates for the patient, corporate, and investment communities by educating policymakers on the role of venture capital in bringing promising, innovative treatments to patients in need.
What We Do
Help ensure a level global playing field for investment and promote policies that empower life science innovators to build and grow in the United States.
Strengthen and protect U.S. intellectual property provisions by promoting patent and regulatory systems that encourage life sciences innovation.
Amplify the results
Spotlight the venture capital-driven breakthroughs that are transforming medicine for patients and health professionals around the globe.
See our webinar, featuring DLA Piper, on the Inflation Reduction Act healthcare provisions.
Incubate issued the following statement in response to amendment 5284 of the Inflation Reduction Act:
Via Bloomberg: Drugmakers have long said R&D will suffer if prices regulated
Stories from the Early-Stage Life Sciences Ecosystem
Listen to industry experts delve into the process behind scientific breakthroughs (and how many of them almost never happened), where the life science ecosystem is taking us next, and most importantly, what it means for patients.
AAPS 2022 Annual Meeting and Exposition (PharmaSci360)
Founded in 1986, the American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific organization of approximately 7,000 individual members…